Live Breaking News & Updates on Riccardo Lencioni

Stay updated with breaking news from Riccardo lencioni. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TACE Plus Durvalumab and Bevacizumab Could Alter SOC in Embolization-Eligible, Unresectable HCC

Riccardo Lencioni, MD, discusses how TACE, durvalumab, and bevacizumab, could represent a new standard of care in embolization-eligible HCC. ....

Italy , Riccardo-lencioni , Department-of-surgery , Cancers-symposium , Critical-area-pathology , Riccardo-lencioni , D , Chemoembolization-tace- , Urvalumab-imfinzi- , Nd-bevacizumab-avastin- , Hepatocellular-carcinoma , Hcc

Durvalumab Plus Bevacizumab Improves TACE Outcomes in HCC

A new study showed improved progression-free survival when systemic therapy is added to TACE for HCC. Overall survival outcomes are pending. ....

United-states , Italy , New-york , American , Josep-llovet , Riccardo-lencioni , University-of-pisa , American-society-of-clinical-oncology , American-society , Clinical-oncology , Mount-sinai-hospital , Hepatocellular-carcinoma-hcc-liver-cancer-of-the

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium. ....

United-states , American , Riccardo-lencioni , Michiels-van , Drug-administration , American-society , Clinical-oncology , Gastrointestinal-cancers-symposium , Genitourinary-cancers , Gastrointestinal-cancers , Der-heijden , Neal-shore

Imfinzi, Avastin, TACE May 'Set a New Standard of Care' in Liver Cancer

Adding Imfinzi and Avastin to transarterial chemoembolization led to a 23% reduction in the risk of progression or death in patients with liver cancer. ....

Italy , Japan , Imfinzi-avastin , Riccardo-lencioni , Department-of-surgery , Critical-area-pathology , Asco-gastrointestinal-cancers-symposium , Liver-cancer ,

New Standard for Unresectable Hepatocellular Carcinoma?

Adding durvalumab and bevacizumab to transarterial chemoembolization almost doubles PFS ....

Italy , Barcelona , Comunidad-autonoma-de-cataluna , Spain , New-york , United-states , Josepm-llovet , Charles-bankhead , Riccardo-lencioni , University-of-barcelona , University-of-pisa , Icahn-school-of-medicine-at-mount-sinai